2 completed. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 2 |
Follow Emd Serono: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients Avelumab, Stereotactic ablative radiotherapy (SAR) - Metastatic Non-small Cell Lung Cancer (NSCLC) | Early Phase 1 | Completed | Megan Daly, MD | 8 | 2017-05-17 | 2021-10-20 |
| Combination Therapy Using Cellcept and Rebif in RRMS mycophenolate mofetil (Cellcept), human interferon beta 1a (Rebif) - Multiple Sclerosis | Early Phase 1 | Completed | Aaron Boster | 31 | 2006-08-01 | 2012-11-15 |
Carcinoma, Non-Small-Cell Lung (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Interferon beta-1a (1) · Mycophenolic Acid (1) · Radiosurgery (1) · avelumab (1)
United States (2)
Aaron L Boster, MD (1) · Megan Daly, MD (1)